We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+2.53%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$5.41B
AUM Growth
+$138M
Cap. Flow
+$23.7M
Cap. Flow %
0.44%
Top 10 Hldgs %
64.34%
Holding
812
New
73
Increased
397
Reduced
244
Closed
59

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Financials 2.57%
3 Healthcare 2.28%
4 Communication Services 1.78%
5 Consumer Discretionary 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
126
Linde
LIN
$221B
$2.69M 0.05%
6,130
+482
+9% +$212K
BLK icon
127
Blackrock
BLK
$169B
$2.69M 0.05%
3,413
+129
+4% +$101K
TJX icon
128
TJX Companies
TJX
$174B
$2.62M 0.05%
23,778
+323
+1% +$32.5K
ITW icon
129
Illinois Tool Works
ITW
$82.6B
$2.6M 0.05%
10,987
+275
+3% +$67.9K
IJS icon
130
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
$2.6M 0.05%
26,758
-6,576
-20% -$646K
VRTX icon
131
Vertex Pharmaceuticals
VRTX
$121B
$2.51M 0.05%
5,348
+470
+10% +$204K
VOT icon
132
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.2B
$2.48M 0.05%
10,796
DE icon
133
Deere & Co
DE
$160B
$2.48M 0.05%
6,626
-442
-6% -$172K
BSX icon
134
Boston Scientific
BSX
$69.5B
$2.45M 0.05%
31,840
+4,779
+18% +$350K
HIG icon
135
Hartford Financial Services
HIG
$38.9B
$2.45M 0.05%
24,349
+1,811
+8% +$182K
CAT icon
136
Caterpillar
CAT
$375B
$2.4M 0.04%
7,196
+113
+2% +$39.2K
SYK icon
137
Stryker
SYK
$125B
$2.39M 0.04%
7,023
-16
-0.2% -$5.42K
VZ icon
138
Verizon
VZ
$195B
$2.37M 0.04%
57,557
+1,915
+3% +$77.2K
HUM icon
139
Humana
HUM
$43.7B
$2.37M 0.04%
6,335
+4,926
+350% +$1.66M
CI icon
140
Cigna
CI
$73.7B
$2.33M 0.04%
7,035
-985
-12% -$340K
VRSK icon
141
Verisk Analytics
VRSK
$25.4B
$2.32M 0.04%
8,609
+334
+4% +$81.7K
IBM icon
142
IBM
IBM
$211B
$2.29M 0.04%
13,264
-1,103
-8% -$192K
PGR icon
143
Progressive
PGR
$123B
$2.29M 0.04%
11,036
+533
+5% +$112K
BIV icon
144
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$2.28M 0.04%
30,383
+447
+1% +$33.2K
WFC icon
145
Wells Fargo
WFC
$261B
$2.26M 0.04%
37,991
+2,206
+6% +$130K
AZN icon
146
AstraZeneca
AZN
$263B
$2.24M 0.04%
14,364
+2,556
+22% +$385K
MPC icon
147
Marathon Petroleum
MPC
$92.4B
$2.19M 0.04%
12,651
+491
+4% +$91.3K
DIS icon
148
Walt Disney
DIS
$167B
$2.19M 0.04%
22,084
-2,199
-9% -$237K
WM icon
149
Waste Management
WM
$90.6B
$2.18M 0.04%
10,231
+511
+5% +$106K
CB icon
150
Chubb
CB
$135B
$2.18M 0.04%
8,545
-63
-0.7% -$16.2K

Similar funds

Ballentine Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ballentine Partners held 812 positions worth $5.41B, up 2.6% from $5.27B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Ballentine Partners's Q2 2024 filing shows 73 new, 397 increased, 244 reduced and 59 closed positions. Its largest new stake was Forrester Research: 250,057 shares worth $4.27M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $11.9M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 5.6% a quarter earlier, followed by Financials and Healthcare.

  • Ballentine Partners's largest Q2 2024 buy was Forrester Research: 250,057 shares worth $4.27M.
  • Ballentine Partners added most to iShares Core MSCI EAFE ETF in Q2 2024, an estimated $11.9M increase.
  • Ballentine Partners's biggest Q2 2024 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $11.9M.
  • Ballentine Partners fully exited State Street SPDR S&P Biotech ETF in Q2 2024, selling an estimated $2.57M.
  • Ballentine Partners's ten largest holdings make up 64% of its $5.41B portfolio in Q2 2024.
  • Ballentine Partners opened 73 new positions and closed 59 in Q2 2024.
  • Ballentine Partners's portfolio value rose 2.6% quarter-over-quarter to $5.41B.

Based on Ballentine Partners's 13F filing for Q2 2024, filed 6 Aug 2024.